Aptiv Solutions

For profit

Also known as: Fulcrum Pharma | Fulcrum Pharma (Europe) Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2004

Last known activity

Aug 1, 2013

Acquired by ICON on May 8, 2014

Timeline

1980s

Jun 1, 1980
Aptiv Solutions— Founded

2000s

Jul 31, 2006
Millennix— Acquired
Nov 1, 2007
Hespirion— Acquired

2010s

May 7, 2014
ClinResearch, GmbH— Acquired
May 8, 2014
ICON— Acquired By

Drugs by trial phase (25 distinct, 16 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (7 own, 7 via acquisition)

Phase 1 (3 own, 2 via acquisition)

Indications

Studied for

Subsidiaries (3 direct, 4 total across the full acquisition tree)

Recent trials (8)

NCT01937767CollaboratorPhase 2Aug 1, 2013
NCT01874028CollaboratorPhase 1May 1, 2013
NCT01379989CollaboratorPhase 3Jun 1, 2011
NCT00960180Study directorPhase 1Jul 1, 2010
NCT01097668CollaboratorPhase 1Mar 1, 2010
NCT00859716CollaboratorPhase 2Oct 1, 2008
NCT00209417CollaboratorPhase 4Jun 1, 2005
NCT00596752CollaboratorPhase 4Mar 1, 2004

Details

Founded: Southborough, MA, US Jun 1, 1980
Last known activity: Aug 1, 2013

Notes

--- Pre-folding founded info: 1983-01-01 Reston VA US https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=2706533 --- --- Notes from Averion International Corporation: CRO ---